Top Markets
#1 Islamic Coin Islamic Coin +152.23%
#2 Bitway Bitway +56.20%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +37.62%
#4 Starpower Starpower +37.41%
#5 Pons Pons +20.79%
#6 aelf aelf +19.30%
#7 Pleasing Gold Pleasing Gold +18.54%
#8 Venom Venom +15.92%
#9 Decred Decred +14.18%
#10 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +14.08%
Coin of the day
Islamic Coin Islamic Coin
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Devonian Health Group Inc. Devonian Health Group Inc.

Devonian Health Group Inc.

DVHGF
Kedudukan dalam Saham #29820
Devonian Health Group Inc. specializes in the creation of botanical-based... Devonian Health Group Inc. specializes in the creation of botanical-based pharmaceutical drugs. Its leading product candidate, Thykamine, is currently undergoing Phase IIa clinical trials to treat conditions such as ulcerative colitis and atopic dermatitis. The company's development pipeline also includes Pantoprazole Magnesium for addressing gastric or duodenal ulcers, Cleo-35 targeting hormonal acne in women, and a range of value-added dermo-cosmetic products. Beyond its own development efforts, Devonian acquires licenses for and distributes various pharmaceutical and health products. Furthermore, the company has established a strategic partnership with CannTx Life Sciences Inc. to collaborate on the development of cannabinoid-based pharmaceutical drugs. Devonian Health Group Inc. was founded in 2015 and is based in Québec, Canada.
Harga Saham
$7.00
Disegerakkan terakhir: 2026-08-17
Modal Pasaran
$19.47M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-35.19%
Negara
CA
Perdagangan Devonian Health Group Inc. (DVHGF)

Kategori

Healthcare
Pendapatan untuk Devonian Health Group Inc. (DVHGF)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Devonian Health Group Inc., pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Devonian Health Group Inc. dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR